California, Connecticut, New York, New Jersey and Washington, D.C., ranked among the U.S. jurisdictions with the most progressive individual income tax systems, according to a recent Tax Foundation analysis.
American Institute-Clifton, Eastwick College-Nutley and Parisian Beauty School enrolled the most in-state students of all two-year New Jersey schools, according to a Higher Education Tribune analysis of fall 2017 data.
New Jersey ranked No. 44 among the District of Columbia and the 50 states in a recent analysis by WalletHub.com on how they were affected by the 35-day partial shutdown of the federal government.
Charlotte Russe Holdings Corporation, the parent company for women’s clothing retailer Charlotte Russe, filed for Chapter 11 bankruptcy protection on Monday and announced that it intends to close three of its 18 stores in New Jersey.
Here are the most popular states for college baseball
New Jersey finished at No. 50 among the 50 states in the Washington-based Tax Foundation’s analysis of how states’ tax systems affect their ability to attract and retain businesses.
The number of vacant homes in the Atlantic City area was nearly 2,500 in the third quarter of 2018, a 1,583-unit decrease over what it was a year ago, according to new real estate numbers reported by ATTOM Data Solutions.
Here are the most popular states for college softball
Join us for a lunch date “crunching” around in support of our member restaurant communities and what we do best, networking!
Workforce Education Committee - February
In the aftermath of the 2018 midterm elections, the Democratic Party won the majority in the House of Representatives and will have a preponderance of voting influence in selecting the next Speaker of the House.
DAIICHI SANKYO, INC: Carrie Ann Inaba Partners with Daiichi Sankyo, Inc. to Encourage Americans to “Get Iron Informed”
Daiichi Sankyo, Inc. today announced a partnership with dancer, choreographer and TV host Carrie Ann Inaba on Get Iron Informed, a campaign to raise awareness of Iron Deficiency Anemia (IDA) – a common type of anemia that can occur when iron levels are insufficient to generate healthy red blood cells.2 Ms. Inaba is partnering with Daiichi Sankyo, Inc. to share her personal experience living with the condition, and reach those who are undiagnosed and at risk so they understand the importance of speaking to their doctor about their iron levels.
MERCK: Merck to Hold Fourth-Quarter and Full-Year 2018 Sales and Earnings Conference Call on February 1
Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter and full-year 2018 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Friday, Feb. 1. During the call, company executives will provide an overview of Merck’s performance for the quarter.
Assumption College for Sisters, Paul Mitchell the School-Jersey Shore and Jersey College enrolled the fewest in-state students of all two-year schools in the U.S., according to a Higher Education Tribune analysis of fall 2017 data.
New Jersey ranked No. 20 among 49 states and U.S. territories that saw reductions in food stamps participation, according to the latest numbers compiled by the Supplemental Nutrition Assistance Program (SNAP).
New Jersey is compliant with a U.S. Supreme Court decision outlining how states can go about requiring online retailers to collect sales taxes on products sold within their borders, according to an analysis by the Washington-based Tax Foundation.
KONICA MINOLTA BUSINESS SOLUTIONS U.S.A., INC: Konica Minolta Launches The MOBOTIX Intelligent Video Security Solution
Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) today announced the launch of its MOBOTIX Intelligent Video Security Solution.
MERCK: Merck’s KEYTRUDA® (pembrolizumab) Reduced Risk of Death by 31 Percent Compared to Chemotherapy in Previously Treated Patients with Advanced Esophageal or Esophagogastric Junction Carcinoma Whose Tumors Expressed PD-L1 (CPS ≥10)
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of results from KEYNOTE-181
DAIICHI SANKYO INC.: Daiichi Sankyo Initiates Pivotal Phase 3 Trial of [Fam-] Trastuzumab Deruxtecan (DS-8201) in HER2 Low Metastatic Breast Cancer
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the first patient has been dosed in DESTINY-Breast04, a global pivotal phase 3 study evaluating the safety and efficacy of [fam-] trastuzumab deruxtecan (DS-8201), an investigational HER2 targeting antibody drug conjugate (ADC), in patients with HER2 low, unresectable and/or metastatic breast cancer previously treated with standard chemotherapy.